$MDCO Recent News Medicines Co. shares fall after FDA

New Post Public Reply Private Reply Replies (0) Message Board

Jun 21, 2014 at 10:19 AM

$MDCO Recent News

Medicines Co. shares fall after FDA panel rejects drug application 11:54 a.m. Feb. 13, 2014 - Russ Britt
FDA reviewing Medicines Co. anti-clotting drug 8:56 a.m. Feb. 12, 2014 - MarketWatch.com
Three biopharma companies poised for product OKs in 2014: analyst 1:51 p.m. Jan. 6, 2014 - Russ Britt
Sam Eisenstadt still bullish on stocks 4:28 p.m. Dec. 27, 2013 - Mark Hulbert
Why I stopped using stop loss orders 8:31 a.m. May 9, 2013 - Michael Sincere
Dow, Nasdaq challenge multiyear highs 1:43 p.m. Feb. 19, 2013 - Michael Ashbaugh
Dow, Nasdaq rattle cage on multi-year highs 12:31 p.m. Feb. 19, 2013 - Michael Ashbaugh
Updates, advisories and surprises 10:01 p.m. July 25, 2012 - MarketWatch
Medicines Co. shares jump 12% on earnings report 12:17 p.m. July 25, 2012 - Val Brickates Kennedy
Corrective bounce, or sustainable upturn? 10:59 a.m. June 6, 2012 - Michael Ashbaugh
Stocks to watch Wednesday: Prestige, Timken, Dell 7:59 a.m. Feb. 22, 2012 - MarketWatch
Friday's biggest gaining and declining stocks 5:25 p.m. Sept. 10, 2010 - MarketWatch
Medicines Co. says patent extension denied 6:29 p.m. March 19, 2010 - Wallace Witkowski
Medicines Co. shares tumble on patent defeat 3:50 p.m. March 19, 2010 - Val Brickates Kennedy
A.P. Pharma, Medicines Co. sink 12:22 p.m. March 19, 2010 - Val Brickates Kennedy
Medicines Co. shares reverse, down 9.7% to $8.40 12:01 p.m. March 19, 2010 - Wallace Witkowski
Wednesday's biggest gaining and declining stocks 5:08 p.m. March 17, 2010 - MarketWatch
Abraxis soars; Molecular Insight falls 1:14 p.m. March 17, 2010 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 5:27 p.m. Feb. 17, 2010 - MarketWatch
Medicines Co. gets wider EU OK for anticoagulant 5:03 a.m. Dec. 1, 2009 - Robert Daniel

As Antibiotics Stop Working, Five Biotechs Seek Cures 8:13 a.m. June 20, 2014 - 247WallSt.com
Top Swing Trade Ideas for Wednesday June 11: Facebook, Vivus, More 9:37 a.m. June 11, 2014 - TheStreet.com
Phase 3 results for oritavancin 7:32 a.m. June 5, 2014 - Seeking Alpha
The Medicines Company (MDCO): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. May 30, 2014 - Zacks.com
Long Swing Picks After the Memorial Day Weekend: Isis, Tibco, More 11:12 a.m. May 27, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – SRPT ISIS MDCO NPSP 8:30 a.m. May 23, 2014 - InvestorPlace.com
10-Q: MEDICINES CO /DE 2:43 p.m. May 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Antibiotics Approvals to Surge 7:06 a.m. May 12, 2014 - Barrons.com
CRL for The Medicines Co.'s Cangrelor - Analyst Blog 4:05 p.m. May 1, 2014 - Zacks.com
Medicines Company gets a CRL on antiplatelet drug 10:35 a.m. May 1, 2014 - Seeking Alpha
Biotech Stock Roundup: Gilead's Sovaldi Shines, Biogen & Alexion Up Outlook - Analyst Blog 10:55 a.m. April 30, 2014 - Zacks.com
The Medicines Co.'s Q1 Earnings Surpass Expectations - Analyst Blog 11:40 a.m. April 24, 2014 - Zacks.com
The Medicines Company's CEO Discusses Q1 2014 Results - Earnings Call Transcript 1:00 p.m. April 23, 2014 - Seeking Alpha
Notable earnings before Wednesday’s open 12:05 a.m. April 23, 2014 - Seeking Alpha
Notable earnings before Wednesday’s open 5:30 p.m. April 22, 2014 - Seeking Alpha
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog 10:07 a.m. April 16, 2014 - Zacks.com
Biotech Stock Roundup: MannKind Soars on Panel Vote, Halozyme Plunges on Safety Concerns - Analyst Blog 12:46 p.m. April 9, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – WCG MDCO PCRX CNC 1:15 p.m. April 8, 2014 - InvestorPlace.com
The Medicines Co's Fibrocaps Under U.S. Review - Analyst Blog 6:08 p.m. April 4, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – ISRG QCOR NVDQ MDCO 7:15 a.m. April 3, 2014 - InvestorPlace.com

Health Care Sector Equities Coverage -- Research on Johnson and Johnson, Medicines Co., Merck, and Novo Nordisk 7:40 a.m. June 13, 2014 - PR Newswire - PRF
Dosing Initiation, Conferences Participation, Trial Results Publication, and Financial Results - Analyst Notes on Arena, Acceleron Pharma, HealthSouth, The Medicines Company and Taro 5:40 a.m. June 10, 2014 - PR Newswire - PRF
ORBACTIVTM (Oritavancin) Phase 3 Trial Results Published in New England Journal of Medicine 6:01 a.m. June 5, 2014 - BusinessWire - BZX
The Medicines Company to Participate in Goldman Sachs 35th Annual Global Healthcare Conference 4:21 p.m. June 4, 2014 - BusinessWire - BZX
Critical Alerts For Microsoft, Medicines, LinkedIn, Priceline, and Qihoo 360 Technology Released By InvestorsObserver 9:31 a.m. May 29, 2014 - PR Newswire - PRF
The Medicines Company to Participate in 2014 Jefferies Global Healthcare Conference 3:54 p.m. May 27, 2014 - BusinessWire - BZX
Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal 7:01 a.m. May 22, 2014 - BusinessWire - BZX
Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co. 7:20 a.m. May 16, 2014 - PR Newswire - PRF
Technical Coverage on Pharma Equities -- Research on Allergan, Actavis, Medicines Co., and Akorn 11:30 a.m. May 9, 2014 - PR Newswire - PRF
The Medicines Company to Host Surgery and Perioperative Care Investor and Analyst Meeting on May 22 12:09 p.m. May 8, 2014 - BusinessWire - BZX
The Medicines Company to Participate in 2014 Bank of America Global Healthcare Conference 1:58 p.m. May 6, 2014 - BusinessWire - BZX
The Medicines Company and Alnylam Announce Presentation of New Pre-Clinical Data on PCSK9 at Arteriosclerosis, Thrombosis and Vascular Biology 2014 Scientific Sessions 11:02 a.m. May 1, 2014 - Marketwire
The Medicines Company Receives Complete Response Letter From FDA Requesting Additional Information for New Drug Application for Its Antiplatelet Agent Cangrelor 7:44 p.m. April 30, 2014 - Marketwire
Generic Drugs Industry Announces Earnings Results, Leadership Appointments, and Conference Participation - Analyst Notes on Mylan, Zoetis, Hospira, Horizon Pharma and The Medicines Co 8:00 a.m. April 30, 2014 - PR Newswire - PRF
Critical Alerts For American Express, Time Warner, Nasdaq OMX Group, The Medicines Company, and PetSmart By InvestorsObserver 9:31 a.m. April 25, 2014 - PR Newswire - PRF
The Medicines Company Adds Novel, Approved, Surgical Sealant to Its Surgical Hemostasis Portfolio 7:02 a.m. April 23, 2014 - Marketwire
The Medicines Company Reports First Quarter 2014 Financial Results 7:02 a.m. April 23, 2014 - Marketwire
THE MEDICINES COMPANY 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against the Medicines Company - MDCO 10:01 p.m. April 18, 2014 - GlobeNewswire
Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Pharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines 12:30 p.m. April 10, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fermi's Leadership Saga: Proxy Wars and Power Struggles

Unfolding the Drama at Fermi (NASDAQ:FRMI) You'd think you were watching a suspense drama unfold, not an annual shareholder meeting report. The co-founder of Fermi, Toby Neugebauer, stepped into the spotlight, throwing shade at Rick Perry and the board's shaky status quo. Pitting Shareholders Against the Board Neugebauer isn't mincing words about the current state of...

SM Investments Wins Five Golden Arrows: Governance on Point

Gold Arrows and Golden Standards What’s in a bunch of gold arrows, you might ask? Well, for SM Investments Corporation, those Five Golden Arrows from the Institute of Corporate Directors aren't just shiny trinkets. They're badges of honor, symbols of a rock-solid governance fortress. For the third year running, they’ve nailed the top spot under the corporate...

212NYC Gala Celebrates Ad Industry's Human Touch

The Advertising Gala with Heart When you toss nearly 300 advertising honchos into a room at Tribeca's Rooftop, you don't just get another bash; you get an industry checkpoint. This time, the 212NYC shindig on November 5, 2026, wasn't just about stroking egos. It was about spotlighting the soul in business, right when AI threatens to run wild with it. Navigating AI's...

Pepsi Drivers in Georgia Gear Up for a Strike Showdown

Teamsters Turn Up the Heat in Georgia Well, folks, buckle up because we've got ourselves a brewing labor storm down in Georgia! Over 100 Pepsi-Cola drivers, holding the steering wheel firm under Teamsters Local 528, are about ready to slam their fists down and go on strike. They've had it up to here with management's tap-dancing around negotiations. Drivers Say Enough Is...

IRTC Faces Investigation: Shares Plunge Amid Uncertainty

Securities Trouble on the Horizon: IRTC Takes a Hit Wake up and adjust your seat, folks—iRhythm Technologies (NASDAQ:IRTC) is in the spotlight, and it ain't pretty. Shares nosedived over 30% in a single morning, stirring up quite the murky waters for shareholders. The trigger? A less-than-stellar third-quarter report. The Numbers Don't Lie—Or Do They? Management...

Havertys Dividend: A Steady Payout Tradition Continues

Another Year, Another Dividend for Havertys Man, talk about a company with a rock-solid habit. Havertys Furniture Companies (NYSE: HVT) just announced its latest cash dividend, cementing a tradition that's been rolling since 1935. They're dropping $0.33 per share on the common stock and $0.31 on the Class A common stock. It's set to hit investors' pockets by December 9,...

Lilly's Digital Healthcare Push with Hims & Hers

Revolutionizing Access: Pharmaceuticals Meet Telehealth In an era where digital disruption is shaking every sector, Eli Lilly (NYSE:LLY) isn't sitting idle. They've just forged a partnership with Hims & Hers (NYSE:HIMS), one that's diving headfirst into the telehealth revolution. We're talking a slick merger of pharmaceuticals and digital platforms—offering FDA-approved...

QORAI CORP's Q4 Nexus: A New AI Frontier

Breakthrough in AI: Enter Q4 Nexus It's not every day you see a tech player emerge with something genuinely fresh—QORAI CORP is shaking up the scene with its Q4 Nexus platform. This isn't just another AI model upgrade. We're talking about a rethink of the very architecture we rely on to power these systems. Founder Robby Joshi's brainchild, Q4 Nexus, jazzes up the AI...

Teneo Expands Financial Advisory in Canada, Eyes Talent

Turning the Maple Leaf Over: Teneo's Move Alright, here's the scoop: Teneo is muscling its way north, into Canada, to flex its Financial Advisory chops. With a lineup of 60 professionals already setting the pace across Toronto, Montreal, and Calgary, this move isn’t just smoke—it’s a full-fledged expansion. They're under the hood, tinkering away to beef up...

Lululemon Faces Class Action Amid Sales Decline

Looks like Lululemon Athletica Inc. (NASDAQ: LULU) is in the hot seat, and not in the cozy yoga session kind of way. Investors are gearing up for a legal face-off thanks to a class action lawsuit alleging some serious corporate sleight of hand. What Triggered This Legal Storm? Turns out, between March 18 and September 3, 2026, things didn't go as planned for Lululemon....